Weekly Digest – March 2025 Weekly Digest – March 2025 03 March 2025: ENHERTU demonstrated statistically significant and clinically meaningful improvement in overall survival in patients with HER2 positive metastatic gastric cancer at interim analysis of DESTINY-Gastric04 Phase 3 trial […]